​

Mereo BioPharma Group Ownership | Who Owns Mereo BioPharma Group?

OverviewForecastRevenueFinancialsChart

Mereo BioPharma Group Ownership Summary

Mereo BioPharma Group is owned by 2.47% institutional investors, 0.96% insiders, and 96.56% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 9.57% of MREO shares. abrdn World Healthcare is the top mutual fund, with 1.83% of its assets in Mereo BioPharma Group shares.

MREO Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMereo BioPharma Group2.47%0.96%96.56%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryBiotech Stocks 382.13%10.41%-292.54%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Rubric capital management lp15.31M9.57%$6.38M
Mangrove partners7.79M4.87%$16.05M
683 capital management4.88M3.05%$10.04M
Rock springs capital management lp4.57M2.86%$9.42M
Clearline capital lp3.83M2.40%$7.90M
Alkeon capital management3.70M2.31%$7.62M
Janus henderson group17.12M2.22%$59.84M
Tejara capital2.16M1.35%$899.94K
Ubs asset management americas1.76M1.10%$735.45K
Schonfeld strategic advisors1.73M1.08%$3.57M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Mangrove partners7.79M1.19%$16.05M
Rock springs capital management lp4.57M0.55%$9.42M
683 capital management4.88M0.52%$10.04M
Clearline capital lp3.83M0.36%$7.90M
Knoll capital management260.47K0.29%$536.57K
Tejara capital2.16M0.21%$899.94K
Artia global partners lp475.36K0.15%$979.24K
Monaco asset management sam1.59M0.11%$660.56K
Logos global management lp500.00K0.09%$1.03M
Rubric capital management lp15.31M0.08%$6.38M

Top Buyers

HolderShares% AssetsChange
Janus henderson group17.12M0.03%4.78M
Schonfeld strategic advisors1.73M0.02%823.08K
Monaco asset management sam1.59M0.11%639.30K
Ubs group1.56M0.00%588.26K
683 capital management4.88M0.52%525.00K

Top Sellers

HolderShares% AssetsChange
Frazier life sciences management---9.44M
Deerfield management company, l.p. (series c)---6.71M
Abrdn---5.54M
Goldman sachs group28.03K--2.34M
Morgan stanley1.27M--2.07M

New Positions

HolderShares% AssetsChangeValue
Logos global management lp500.00K0.09%500.00K$1.03M
Entrypoint capital400.70K0.07%400.70K$166.97K
Citigroup195.81K-195.81K$81.60K
Baader bank aktiengesellschaft128.74K0.00%128.74K$33.08K
Virtu financial15.97K0.00%15.97K$33.00K

Sold Out

HolderChange
Grove bank & trust-12.00
Plante moran financial advisors-48.00
Cranbrook wealth management-60.00
Principal securities-75.00
Transce3nd-127.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202514-85.11%3,959,261-96.05%20.06%9-76.92%3-86.96%
Sep 30, 202521-77.66%9,556,446-89.83%54.16%7-84.44%5-70.59%
Jun 30, 202594-3.09%98,564,900-5.55%127.10%437.50%18-10.00%
Mar 31, 2025981.03%111,073,582-3.58%146.33%415.13%21-16.00%
Dec 31, 20249314.81%108,788,6352.89%140.30%3818.75%2623.81%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
abrdn World Healthcare2.90M1.83%1.22M
abrdn Life Sciences Investors2.08M1.31%-
UBS (Lux) EF Biotech (USD) P-acc1.76M1.11%-77.30K
Fidelity Select Health Care1.47M0.92%1.47M
Fidelity Select Biotechnology852.00K0.54%132.60K
Fidelity Advisor Biotechnology I759.10K0.48%-
Fidelity Advisor Health Care I750.42K0.47%750.42K
HealthInvest Sustainable Healthcare E358.90K0.23%358.90K
International Biotechnology Ord351.35K0.22%-
Healthlnvest S&M Cap Healthcare C227.84K0.14%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 13, 2024Scots-Knight Denise Chief Executive OfficerSell$253.45K
Sep 12, 2024Scots-Knight Denise Chief Executive OfficerSell$127.97K
Sep 12, 2024Lewicki John A. Chief Scientific OfficerSell$23.31K
Sep 13, 2024Lewicki John A. Chief Scientific OfficerSell$46.17K
Sep 12, 2024Sermon Charles General CounselSell$44.64K

Insider Transactions Trends

DateBuySell
2026 Q1--
2025 Q1--
2024 Q3-13
2024 Q2-12
2024 Q1--

MREO Ownership FAQ

Who Owns Mereo BioPharma Group?

Mereo BioPharma Group shareholders are primarily institutional investors at 2.47%, followed by 0.96% insiders and 96.57% retail investors. The average institutional ownership in Mereo BioPharma Group's industry, Biotech Stocks , is 382.13%, which Mereo BioPharma Group falls below.

Who owns the most shares of Mereo BioPharma Group?

Mereo BioPharma Group’s largest shareholders are Rubric capital management lp (15.31M shares, 9.57%), Mangrove partners (7.79M shares, 4.87%), and 683 capital management (4.88M shares, 3.05%). Together, they hold 17.49% of Mereo BioPharma Group’s total shares outstanding.

Does Blackrock own Mereo BioPharma Group?

BlackRock is not among the top 10 institutional shareholders of Mereo BioPharma Group.

Who is Mereo BioPharma Group’s biggest shareholder by percentage of total assets invested?

Mangrove partners is Mereo BioPharma Group’s biggest shareholder by percentage of total assets invested, with 1.19% of its assets in 7.79M Mereo BioPharma Group shares, valued at 16.05M$.

Who is the top mutual fund holder of Mereo BioPharma Group shares?

abrdn World Healthcare is the top mutual fund holder of Mereo BioPharma Group shares, with 1.83% of its total shares outstanding invested in 2.9M Mereo BioPharma Group shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools